| Integrative Psychology Services Pllc | |
|
2024 Nw 92nd Ct Ste 12 Clive IA 50325-5462 | |
| (515) 421-8250 | |
| Not Available |
| Full Name | Integrative Psychology Services Pllc |
|---|---|
| Speciality | Clinic/Center |
| Location | 2024 Nw 92nd Ct Ste 12, Clive, Iowa |
| Authorized Official Name and Position | Kevin Kilcawley (LICENSED PSYCHOLOGIST) |
| Authorized Official Contact | 5154218250 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Integrative Psychology Services Pllc 2024 Nw 92nd Ct Ste 12 Clive IA 50325-5462 Ph: () - | Integrative Psychology Services Pllc 2024 Nw 92nd Ct Ste 12 Clive IA 50325-5462 Ph: (515) 421-8250 |
| NPI Number | 1730645102 |
|---|---|
| Provider Enumeration Date | 02/11/2019 |
| Last Update Date | 02/11/2019 |
| Medicare PECOS PAC ID | 2567893787 |
|---|---|
| Medicare Enrollment ID | O20200502000208 |
News Archive
Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.
A self-administered 'scratch-and-sniff' test for COVID-19 may be around the corner, according to researchers at Penn State, the University of Florida and Arizona State University.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730645102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Kevin G Kilcawley |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1710383757 PECOS PAC ID: 3971808320 Enrollment ID: I20160223000092 |
News Archive
Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.
A self-administered 'scratch-and-sniff' test for COVID-19 may be around the corner, according to researchers at Penn State, the University of Florida and Arizona State University.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
› Verified 7 days ago
News Archive
Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.
A self-administered 'scratch-and-sniff' test for COVID-19 may be around the corner, according to researchers at Penn State, the University of Florida and Arizona State University.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
› Verified 7 days ago
Poeppe Expert Psychological Services Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 12951 University Ave Ste 204, Clive, IA 50325 Phone: 515-575-3180 | |
Mercyone Des Moines Neuropsychology Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12493 University Ave Ste 100, Clive, IA 50325 Phone: 515-358-0060 | |
Connected Life Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8450 Hickman Rd Ste A2, Clive, IA 50325 Phone: 515-996-6971 | |
Mercyone Comfort Health Center For Women Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 Nw 114th St Ste 151, Clive, IA 50325 Phone: 515-222-7474 Fax: 515-222-7491 | |
Ellie Mental Health Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 12247 Stratford Dr, Clive, IA 50325 Phone: 515-393-6702 | |
Skt Enterprises, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12447 Stratford Dr, Clive, IA 50325 Phone: 319-855-3549 | |
Exist Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2175 Nw 86th St Ste 10, Clive, IA 50325 Phone: 515-333-2352 |